Blues Plans, California Move to Manufacture Generic Drugs

An earlier version of this article incorrectly stated that all Blue Cross Blue Shield affiliates joined a partnership with Civica Rx. As of Feb. 17, 18 Blues plans had joined the agreement. This version has been corrected.

The high price of prescription drugs has frustrated payers for years. Recently, that frustration has led some insurers to enter the drug production business — and states could follow their lead.

0 Comments
© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has worked as a journalist since 2011 and has covered health care since 2020. At AIS Health, Peter covers trends in finance, business and policy that affect the health insurance and pharma sectors. For Health Plan Weekly, he covers all aspects of the U.S. health insurance sector, including employer-sponsored insurance, Medicaid managed care, Medicare Advantage and the Affordable Care Act individual marketplaces. In Radar on Drug Benefits, Peter covers the operations of (and conflicts between) pharmacy benefit managers and pharmaceutical manufacturers, with a particular focus on pricing dynamics and market access. Before joining AIS Health, Peter covered transportation, public safety and local government for various outlets in Seattle, his hometown and current place of residence. He graduated with a B.A. from Colby College.

Related Posts

inside-congress
June 21

Reports Underscore Risk of Failing to Extend Enhanced ACA Subsidies

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
June 21

News Briefs: Court Upholds ACA Preventive Services Coverage Mandate, for Now

READ MORE
finance-and-economy-chart
June 21

MCO Stock Performance, May 2024

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today